A carregar...
Role of Cerebrospinal Fluid Biomarkers in Clinical Trials for Alzheimer's Disease Modifying Therapies
Until now, a disease-modifying therapy (DMT) that has an ability to slow or arrest Alzheimer's disease (AD) progression has not been developed, and all clinical trials involving AD patients enrolled by clinical assessment alone also have not been successful. Given the growing consensus that the...
Na minha lista:
| Publicado no: | Korean J Physiol Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Physiological Society and The Korean Society of Pharmacology
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4296032/ https://ncbi.nlm.nih.gov/pubmed/25598657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2014.18.6.447 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|